Linden Capital and Audax complete StatLab sale to Danaher’s Leica Biosystems
Monday, September 28, 2026 · first reported by PE Hub
Linden Capital and Audax exit StatLab Medical Products through sale to Danaher's Leica Biosystems division.
- Firm
- Linden Capital
- Also named
- Audax, StatLab Medical Products, Danaher, Leica Biosystems
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Apax in talks to acquire Warburg Pincus stake in €6.5bn Dutch telecoms group OdidoPrivate Equity Wire
- Brixmor Property Group, Everview Partners Acquire Slate Grocery REIT for $2.34BCommercial Observer +2
- CVC Dropped Its Bodycote Pursuit, Clearing the Path for Veritas Capital’s About $2.5 Billion TakeoverHedgeCo Insights +1
- Greenbriar nears $1.8bn deal to acquire Spectrum Control from AEA InvestorsPrivate Equity Wire
- Warburg Pincus raises Ingenia bid againPrivate Equity Wire
- InfraRed-Managed Funds Agreed to Acquire Hector Rail; HICL to Invest About £68 MillionHedgeCo Insights +1